Only established patients may place new orders.


Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by stimulating the GIP and GLP-1 receptors in the body.



GIP and GLP-1 are naturally occurring hormones in the body that are released after a meal to stimulate insulin secretion, reduce glucagon secretion, slow down gastric emptying, and promote satiety. These actions help regulate blood sugar levels and control appetite.

Tirzepatide mimics the action of GIP and GLP-1, leading to increased insulin secretion from the pancreas, decreased glucagon secretion from the liver, slower emptying of the stomach, and a feeling of fullness. This results in improved glycemic control, reduced blood sugar levels, and potential weight loss.

TIRZEPATIDE works for type 2 diabetes, as well as, for weight loss in several ways by helping the body release insulin when blood sugar is high, removing excess sugar from the blood, stopping the liver from making and releasing too much sugar, reducing hunger/appetite, and improving satiety by slowing down digestion.



1-4 2.5 mg (25units)

5-8 5mg (50 units)

9-12 7.5 mg (75 units)

13-16 10 mg (100 units)

17-20 12.5 mg (125 units)

21-24 15 mg (150 units)

Note:  if you are losing on your current dose you do not have to increase to the next dose

Additional information


2.5mg, 5mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg


4 weeks, 8 weeks, 16 weeks